Species Distribution and Antifungal Susceptibility Pattern of Candida Isolates Causing Neonatal Sepsis in a Tertiary-Care NICU
International Journal of Contemporary Microbiology · 2026
DOI: 10.37506/401g5208 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Contemporary Microbiology, 2026. Verfasst von Ajitesh Singh und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Sepsis, Neonatologie
Abstract (Originalsprache)
Background
A global shift from Candida albicans to non-albicans candida (NAC) species has been reported in neonatal candidemia, with important implications for empirical antifungal choice given differing susceptibility profiles, and the recent emergence of the multidrug-resistant species Candida auris adds further urgency to local surveillance.
Objective
To determine the species distribution and antifungal susceptibility pattern of candida isolates causing neonatal sepsis in a tertiary-care NICU, and to examine whether this distribution differed by specimen type (blood vs urine).
Methods
In a prospective study conducted from January 2020 to July 2021, candida isolates obtained from blood, CSF, or urine of neonates with culture-proven candida sepsis were identified to species level using germ tube testing or MALDI-TOF, as appropriate. Antifungal susceptibility to fluconazole, voriconazole, amphotericin B, and caspofungin was determined by the CLSI-based disc diffusion method and isolates were classified as sensitive, resistant, or dose-dependent sensitive (SDD). Given the small size of several species subgroups, 95% confidence intervals (Wilson score method) were calculated for key proportions to convey estimate precision.
Results
Sixty-four candida isolates were obtained from 62 neonates. Non-albicans candida (NAC) accounted for 55 isolates (85.9%) and Candida albicans for 9 (14.1%). Candida tropicalis was the most common isolate overall (23.4%), followed by C. utilis (20.3%), C. krusei (17.2%), and C. albicans (14.1%); C. auris was isolated in 3 neonates (4.7%). The species distribution differed somewhat between blood and urine isolates, with C. albicans proportionally more frequent among urinary isolates (28.6%) than blood isolates (11.3%). Overall, 62.5% of isolates were sensitive to fluconazole (with a further 18.9% dose-dependent sensitive), 92.2% to voriconazole, 95.3% to amphotericin B, and 100% to caspofungin. Fluconazole resistance was numerically higher among NAC than C. albicans isolates (41.8%, 95% CI 29.7–55.0% vs 11.1%, 95% CI 2.0–43.5%; Fisher's exact p=0.07); the markedly wider confidence interval around the C. albicans estimate reflects the small denominator (n=9) for that group and should temper interpretation of the point estimate. C. glabrata showed complete (100%) resistance to fluconazole, and C. auris showed high resistance (66.6%) across fluconazole, voriconazole, and amphotericin B, while remaining universally susceptible to caspofungin.
Conclusion
Non-albicans candida species predominated in this cohort, with C. tropicalis the commonest isolate. Fluconazole resistance was substantial, particularly among NAC and emerging species such as C. auris and C. glabrata, while susceptibility to caspofungin and amphotericin B remained high, supporting their role in empirical therapy pending species identification.
Zitieren
APA
Singh, A., Mukhopadhyay, S., & Kumar, M. (2026). Species Distribution and Antifungal Susceptibility Pattern of Candida Isolates Causing Neonatal Sepsis in a Tertiary-Care NICU. International Journal of Contemporary Microbiology. https://doi.org/10.37506/401g5208
Vancouver
Singh A, Mukhopadhyay S, Kumar M. Species Distribution and Antifungal Susceptibility Pattern of Candida Isolates Causing Neonatal Sepsis in a Tertiary-Care NICU. International Journal of Contemporary Microbiology. 2026. doi:10.37506/401g5208
BibTeX
@article{Singh2026,
author = {Singh, Ajitesh and Mukhopadhyay, Sanjukta and Kumar, Mala},
title = {Species Distribution and Antifungal Susceptibility Pattern of Candida Isolates Causing Neonatal Sepsis in a Tertiary-Care NICU},
journal = {International Journal of Contemporary Microbiology},
year = {2026},
doi = {10.37506/401g5208}
}
EUVIMED